Real-world outcomes in patients with moderate-to-severe plaque psoriasis treated with guselkumab for up to 1 year

Marco Galluzzo, Marina Talamonti, Nicoletta Bernardini, Andrea Chiricozzi, Clara De Simone, Claudio Bonifati, Pierluigi Bruni, Federico Diotallevi, Maria Esposito, Dario Graceffa, Katharina Hansel, Francesco Loconsole, Gaia Moretta, Cristina Mugheddu, Manuela Papini, Antonio Richetta, Nevena Skroza, Laura Atzori, Maria Concetta Fargnoli, Severino PersechinoAnnamaria Offidani, Luca Stingeni, Ketty Peris, Concetta Potenza, Luca Bianchi

Department of Medicine and Translational Surgery
Faculty of Medicine and Surgery
Academic Field: Medical Specialities

University of Rome Tor Vergata
University of Rome La Sapienza
IRCCS Istituto Dermatologico Santa Maria e San Gallicano – Roma
University of Perugia
Marche Polytechnic University
University of L'Aquila
University of Bari
IRCCS Istituto Dermopatico dell'Immacolata - Roma
University of Cagliari

Research output: Contribution to journal › Article

Sort by
Weight
Alphabetically

Real-world outcomes in patients with moderate-to-severe plaque psoriasis treated with guselkumab for up to 1 year

Fingerprint

Nursing and Health Professions

Medicine and Dentistry